PayLineHQ runs your application through a simulated Study Section before NIH does. Three reviewer perspectives, three-pass quality review, citation verification, and a competitive impact score — so you fix what real reviewers would have flagged, before they count.
No credit card · No commitment · 30 sec to first reviewer score
You stay the principal investigator. We bring the structure, reviewer psychology, and the QA your draft needs.
Our Study Section simulation surfaces the same weaknesses real reviewers will flag — so you fix them before they count.
Across every dimension biotech founders actually care about.
I'm Eddie Bannerman-Menson, founder of COARE Holdings. We're developing DCLK1-targeted CAR-T cell therapy for ovarian cancer. Like every biotech founder, my path to the clinic runs through non-dilutive funding — primarily NIH SBIR/STTR.
I spent years writing applications, waiting 9 months, watching them get triaged for fixable reasons — vague innovation framing, underpowered statistics, citations that didn't quite support the claim. Reviewers caught what I couldn't see. There was no way to simulate their perspective before submission.
PayLineHQ is what I wished existed. It runs your application through three independent reviewer simulations using 25 years of NIH peer-review psychology, scores it against real funding lines, and tells you exactly what to fix before NIH does. The same engine that's now writing my COARE submissions.
If it works for me, it works for you.
Self-Serve for hands-on PIs. Submit-Ready when you'd rather we drive.
Phase II / Fast Track from $4,500 · R01/R21 from $3,500 · Full pricing
Start free in the app, or book a call and we'll write the whole thing.